Search research articles
Contact Us
Filters
Showing results (611-620 of 657) with videos related to
Page
of 66
Sort By:
The American Journal of Surgical Pathology
|
March 2, 2017
Immunophenotypic Shifts in Primary Cutaneous γδ T-Cell Lymphoma Suggest Antigenic Modulation: A Study of Sequential Biopsy Specimens
Rose Lou Marie C Agbay, Carlos A Torres-Cabala, Keyur P Patel, et al.
Journal of Cutaneous Pathology
|
January 11, 2024
Nectin-4 expression in a subset of cutaneous adnexal carcinomas: A potential target for therapy with enfortumab vedotin
Woo Cheal Cho, Rayan Saade, Priyadharsini Nagarajan, et al.
The Journal of Clinical Investigation
|
June 4, 2013
MicroRNA-mediated loss of ADAR1 in metastatic melanoma promotes tumor growth
Yael Nemlich, Eyal Greenberg, Rona Ortenberg, et al.
Journal of Cutaneous Pathology
|
March 11, 2015
Use of clinical next-generation sequencing to identify melanomas harboring SMARCB1 mutations
David L Stockman, Jonathan L Curry, Carlos A Torres-Cabala, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 18, 2004
Phase I trial of preoperative doxorubicin-based concurrent chemoradiation and surgical resection for localized extremity and body wall soft tissue sarcomas
Peter W T Pisters, Shreyaskumar R Patel, Victor G Prieto, et al.
Journal of the National Cancer Institute
|
December 22, 2005
In vitro sensitivity to ultraviolet B light and skin cancer risk: a case-control analysis
Li-E Wang, Ping Xiong, Sara S Strom, et al.
The Oncologist
|
March 5, 2013
Analysis of dermatologic events in vemurafenib-treated patients with melanoma
Mario E Lacouture, Madeleine Duvic, Axel Hauschild, et al.
Plos One
|
September 8, 2017
SCF-KIT signaling induces endothelin-3 synthesis and secretion: Thereby activates and regulates endothelin-B-receptor for generating temporally- and spatially-precise nitric oxide to modulate SCF- and or KIT-expressing cell functions
Lei L Chen, Jing Zhu, Jonathan Schumacher, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 8, 2014
Molecular profiling of patient-matched brain and extracranial melanoma metastases implicates the PI3K pathway as a therapeutic target
Guo Chen, Nitin Chakravarti, Kimberly Aardalen, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
May 20, 2008
Evolution from heterozygous to homozygous KIT mutation in gastrointestinal stromal tumor correlates with the mechanism of mitotic nondisjunction and significant tumor progression
Lei L Chen, Joseph A Holden, Haesun Choi, et al.
Page
of 66
Search research articles
Search
Showing results (611-620 of 657) with videos related to
Sort By:
Page
of 66
The American Journal of Surgical Pathology
|
March 2, 2017
Immunophenotypic Shifts in Primary Cutaneous γδ T-Cell Lymphoma Suggest Antigenic Modulation: A Study of Sequential Biopsy Specimens
Rose Lou Marie C Agbay, Carlos A Torres-Cabala, Keyur P Patel, et al.
Journal of Cutaneous Pathology
|
January 11, 2024
Nectin-4 expression in a subset of cutaneous adnexal carcinomas: A potential target for therapy with enfortumab vedotin
Woo Cheal Cho, Rayan Saade, Priyadharsini Nagarajan, et al.
The Journal of Clinical Investigation
|
June 4, 2013
MicroRNA-mediated loss of ADAR1 in metastatic melanoma promotes tumor growth
Yael Nemlich, Eyal Greenberg, Rona Ortenberg, et al.
Journal of Cutaneous Pathology
|
March 11, 2015
Use of clinical next-generation sequencing to identify melanomas harboring SMARCB1 mutations
David L Stockman, Jonathan L Curry, Carlos A Torres-Cabala, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 18, 2004
Phase I trial of preoperative doxorubicin-based concurrent chemoradiation and surgical resection for localized extremity and body wall soft tissue sarcomas
Peter W T Pisters, Shreyaskumar R Patel, Victor G Prieto, et al.
Journal of the National Cancer Institute
|
December 22, 2005
In vitro sensitivity to ultraviolet B light and skin cancer risk: a case-control analysis
Li-E Wang, Ping Xiong, Sara S Strom, et al.
The Oncologist
|
March 5, 2013
Analysis of dermatologic events in vemurafenib-treated patients with melanoma
Mario E Lacouture, Madeleine Duvic, Axel Hauschild, et al.
Plos One
|
September 8, 2017
SCF-KIT signaling induces endothelin-3 synthesis and secretion: Thereby activates and regulates endothelin-B-receptor for generating temporally- and spatially-precise nitric oxide to modulate SCF- and or KIT-expressing cell functions
Lei L Chen, Jing Zhu, Jonathan Schumacher, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 8, 2014
Molecular profiling of patient-matched brain and extracranial melanoma metastases implicates the PI3K pathway as a therapeutic target
Guo Chen, Nitin Chakravarti, Kimberly Aardalen, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
May 20, 2008
Evolution from heterozygous to homozygous KIT mutation in gastrointestinal stromal tumor correlates with the mechanism of mitotic nondisjunction and significant tumor progression
Lei L Chen, Joseph A Holden, Haesun Choi, et al.
Page
of 66